The Medicines and Healthcare products Regulatory Agency (MHRA) has today (3 June 2026) authorised the medicine resmetirom (Rezdiffra) to treat adult patients with…
Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…